1·The next big target is another surface protein, neuraminidase (see "Moving target").
其次是另一种表面蛋白神经氨酸酶（见 “ 转移攻击 ” ）。
2·Antiviral resistance to neuraminidase inhibitors has been clinically negligible so far but is likely to be detected during widespread use during a pandemic.
到目前为止，对神经氨酸酶抑制剂的抗病毒制剂耐药性，在临床上很微弱，但在大流行期间广泛使用这类抑制剂时可能会出现。
3·Zanamivir and oseltamivir bind differently at the neuraminidase catalytic site and this contributes to different drug resistance profiles.
扎那米韦和奥塞·米韦结合在神经氨酸酶的不同催化位点，这就导致了这种耐药情况不同的发生。
4·M6 gold complexes showed no ability to bind to surface of erythrocytes treated by trypsin or neuraminidase.
M6的胶体金复合物不能与经胰酶和神经氨酸酶处理过的红细胞发生结合。
5·Neuraminidase (NA) is an important protein on the surface of virion and plays an important role in immune and lethality.
神经氨酸酶（NA）是流感病毒表面的一种重要蛋白质，在免疫和致病方面起重要作用。